Skip to content

Drug interactions

Interferon beta 1a + Natalizumab

Severity: Minor

Interferon beta 1a and Natalizumab: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

The two multiple sclerosis agents have been combined in studies without a clinically meaningful pharmacokinetic problem. The legacy suggestion of reduced natalizumab clearance is not well established. Combined use has not shown clear added benefit and may modestly increase adverse effects.

What this interaction means in plain words

Interferon beta 1a and Natalizumab have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Interferon beta 1a belongs to Central Nervous System; Natalizumab belongs to Gastrointestinal Tract.

Evidence level: Low

Why it happens

No well-established mechanism; possible additive immunomodulatory effects.

What to do

No dose change is needed. Monitor for infection and the usual treatment adverse effects.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Interferon beta 1a and Natalizumab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Interferon beta 1a with Natalizumab?

MediHelp rates the interaction as minor. Interferon beta 1a and Natalizumab have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. The two multiple sclerosis agents have been combined in studies without a clinically meaningful pharmacokinetic problem. The legacy suggestion of reduced natalizumab clearance is not well established. Combined use has not shown clear added benefit and may modestly increase adverse effects.

How serious is the interaction between Interferon beta 1a and Natalizumab?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is needed. Monitor for infection and the usual treatment adverse effects.

What other medicines interact with Natalizumab?

MediHelp also lists interactions of Natalizumab with, for example, Vedolizumab, Axicabtagene ciloleucel, Baricitinib. The full list is on the Natalizumab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in